Hidetaka Kawabata Selected Research

Hidetaka Kawabata Research Topics

Disease

19	Breast Neoplasms (Breast Cancer) 02/2022 - 05/2010
10	Neoplasms (Cancer) 02/2022 - 03/2010
2	Triple Negative Breast Neoplasms 01/2022 - 07/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 04/2020 - 06/2017
2	Carcinogenesis 01/2020 - 09/2017
2	Neoplasm Metastasis (Metastasis) 01/2020 - 10/2019
1	Ovarian Neoplasms (Ovarian Cancer) 04/2020
1	Pain (Aches) 04/2020
1	Carcinoma (Carcinomatosis) 12/2019
1	Femoral Fractures (Femoral Fracture) 10/2019
1	Osteoporosis 10/2019
1	Neutropenia 10/2018
1	Pathologic Complete Response 08/2014
1	Chronic Disease (Chronic Diseases) 03/2013
1	Febrile Neutropenia 01/2013
1	Infections 01/2013

Drug/Important Bio-Agent (IBA)

6	Estrogen ReceptorsIBA 02/2022 - 12/2019
6	Hormones (Hormone)IBA 01/2022 - 05/2018
3	Small Interfering RNA (siRNA)IBA 02/2022 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 02/2022 - 09/2017
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 01/2020
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 06/2017
3	Tamoxifen FDA LinkGeneric 01/2022 - 05/2018
3	taxaneIBA 12/2021 - 10/2018
3	eribulin FDA Link 12/2021 - 10/2018
3	Estrogens (Estrogen)FDA Link 10/2021 - 12/2019
2	Bevacizumab (Avastin)FDA Link 01/2022 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2019
2	Taxoids (Taxanes)IBA 12/2021 - 08/2018
2	AnthracyclinesIBA 12/2021 - 07/2021
2	Messenger RNA (mRNA)IBA 01/2020 - 12/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 12/2019
1	LigandsIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	NivolumabIBA 01/2022
1	Octamer Transcription Factor-1IBA 10/2021
1	Organic Cation Transporter 1IBA 10/2021
1	Carboplatin (JM8)FDA LinkGeneric 07/2021
1	Sodium Channels (Sodium Channel)IBA 04/2020
1	RNA Precursors (Precursor, mRNA)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	E2F Transcription FactorsIBA 01/2020
1	Thymopoietins (TP 49)IBA 12/2019
1	Long Noncoding RNAIBA 12/2019
1	Denosumab FDA Link 10/2019
1	human ERBB2 proteinIBA 08/2018
1	Lapatinib (GW572016)FDA Link 08/2018
1	Trastuzumab (Herceptin)FDA Link 08/2018
1	Capecitabine (Xeloda)FDA Link 08/2018
1	Leuprolide (Lupron)FDA LinkGeneric 05/2018
1	Goserelin (Zoladex)FDA Link 05/2018
1	UbiquitinIBA 09/2017
1	Ligases (Synthetase)IBA 09/2017
1	Tripartite Motif ProteinsIBA 09/2017
1	Cytochrome P-450 CYP2C8IBA 06/2017
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 03/2013
1	Transaminases (Aminotransferases)IBA 01/2013
1	exemestane (Aromasin)FDA Link 01/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2010
1	Docetaxel (Taxotere)FDA Link 05/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2010
1	Zoledronic Acid (Zometa)FDA Link 03/2010

Therapy/Procedure

9	Therapeutics 01/2022 - 03/2013
3	Neoadjuvant Therapy 12/2021 - 08/2014
2	Drug Therapy (Chemotherapy) 08/2018 - 01/2013